Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia
- 24 January 2013
- journal article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 39 (4), 693-702
- https://doi.org/10.1007/s00134-013-2829-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort studyJournal of Antimicrobial Chemotherapy, 2011
- Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus InfectionThe New England Journal of Medicine, 2010
- Critical Care Services and 2009 H1N1 Influenza in Australia and New ZealandThe New England Journal of Medicine, 2009
- Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaPublished by American Medical Association (AMA) ,2009
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoThe New England Journal of Medicine, 2009
- Impact of intravenous -lactam/macrolide versus -lactam monotherapy on mortality in hospitalized patients with community-acquired pneumoniaJournal of Antimicrobial Chemotherapy, 2009
- Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenzaCritical Care, 2009
- Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in SpainCritical Care, 2009
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003